Recruiting

Photon/Proton Therapy

Sponsor:

Mayo Clinic

Code:

NCT02457962

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Conditions

Solid Tumors

Hematologic Malignancies

Study ID

NCT02457962

Start date

Apr 23, 2015

Status verified date

Mar, 2026

Completion date

Apr 30, 2031

Anticipated

Primary completion date

Apr 30, 2031

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology
2. Radiation therapy for curative intent

Exclusion Criteria:

None

Study Design

Enrollment

15000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • analyze acute and late toxicities using CTCAE 4.03 [ Time Frame: Patients will be followed for the duration of their life, an expected average of 20 years ]
  • analyze quality of life using LASA-3 and FACT-E [ Time Frame: Patients will be followed for the duration of their life, an expected average of 20 years ]

Central Contacts and Locations

Central contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Locations

Mayo Clinic

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Clinical Trials Referral Office

855-776-0015

Principal Investigator:

Nadia N. Laack, MD

More Information

Sponsor

Mayo Clinic

Last update posted

Apr 1, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-04-01.